Radiolabeled Nanoparticles, Angionesis and Therapeutics of Cancer Researches Together With Preclinical Models

被引：1
|
作者：
Perihan, Unak [1 ]
机构：
[1] Ege Univ, Inst Nucl Sci, Dept Nucl Applicat, Izmir, Turkey
来源：
CURRENT RADIOPHARMACEUTICALS | 2021年 / 14卷 / 01期
关键词：
D O I：
10.2174/187447101401210301124149
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [31] GOLD NANOPARTICLES IN CANCER IMAGING AND THERAPEUTICS
    Huang, Huang-Chiao
    Ramos, James
    Grandhi, Taraka Sai Pavan
    Potta, Thrimoorthy
    Rege, Kaushal
    NANO LIFE, 2010, 1 (3-4) : 289 - 307
  • [32] Preclinical Models of Adrenocortical Cancer
    Sedlack, Andrew J. H.
    Hatfield, Samual J.
    Kumar, Suresh
    Arakawa, Yasuhiro
    Roper, Nitin
    Sun, Nai-Yun
    Nilubol, Naris
    Kiseljak-Vassiliades, Katja
    Hoang, Chuong D.
    Bergsland, Emily K.
    Hernandez, Jonathan M.
    Pommier, Yves
    del Rivero, Jaydira
    CANCERS, 2023, 15 (11)
  • [33] Preclinical models of prostate cancer
    Fizazi, K
    Navone, NM
    BULLETIN DU CANCER, 2005, 92 (02) : 129 - 141
  • [34] Mouse models of colorectal cancer as preclinical models
    McIntyre, Rebecca E.
    Buczacki, Simon J. A.
    Arends, Mark J.
    Adams, David J.
    BIOESSAYS, 2015, 37 (08) : 909 - 920
  • [35] Pharmacokinetics and efficacy of doxorubicin-loaded plant virus nanoparticles in preclinical models of cancer
    Madden, Andrew J.
    Oberhardt, Bruce
    Lockney, Dustin
    Santos, Charlene
    Vennam, Preethi
    Arney, David
    Franzen, Stefan
    Lommel, Steven A.
    Miller, C. Ryan
    Gehrig, Paola
    Zamboni, William C.
    NANOMEDICINE, 2017, 12 (20) : 2519 - 2532
  • [36] Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics
    Logsdon, Craig D.
    Arumugam, Thiruvengadam
    Ramachandran, Vijaya
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2015, 309 (05): : G283 - G291
  • [37] Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer
    Langenau, David M.
    Sweet-Cordero, Alejandro
    Wechsler-Reya, Robert J.
    Dyer, Michael A.
    CANCER RESEARCH, 2015, 75 (24) : 5176 - 5186
  • [38] Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics
    Liu, Joyce F.
    Palakurthi, Sangeetha
    Zeng, Qing
    Zhou, Shan
    Ivanova, Elena
    Huang, Wei
    Zervantonakis, Ioannis K.
    Selfors, Laura M.
    Shen, Yiping
    Pritchard, Colin C.
    Zheng, Mei
    Adleff, Vilmos
    Papp, Eniko
    Piao, Huiying
    Novak, Marian
    Fotheringham, Susan
    Wulf, Gerburg M.
    English, Jessie
    Kirschmeier, Paul T.
    Velculescu, Victor E.
    Paweletz, Cloud
    Mills, Gordon B.
    Livingston, David M.
    Brugge, Joan S.
    Matulonis, Ursula A.
    Drapkin, Ronny
    CLINICAL CANCER RESEARCH, 2017, 23 (05) : 1263 - 1273
  • [39] Active targeting of gold nanoparticles as cancer therapeutics
    Goddard, Zoe Rachael
    Marin, MariaA J.
    Russell, David A.
    Searcey, Mark
    CHEMICAL SOCIETY REVIEWS, 2020, 49 (23) : 8774 - 8789
  • [40] Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer
    Fortina, Paolo
    Kricka, Larry J.
    Graves, David J.
    Park, Jason
    Hyslop, Terry
    Tam, Felicia
    Halas, Naomi J.
    Surrey, Saul
    Waldman, Scott A.
    TRENDS IN BIOTECHNOLOGY, 2007, 25 (04) : 145 - 152
12345